Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
Clinical trial NCT03382964 · COMPLETED
Trial details
- NCT number
- NCT03382964
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2018-07-13
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.